Sentences with phrase «in studying treatment»

The breakthrough modification of CRISPR technology can become an invaluable tool in studying treatment effects on cells.

Parents in both treatments attended over 90 percent of treatment sessions, suggesting that parents were highly engaged in the study treatments.

These results suggest that transplantation of customized stem cells might perhaps be useful in the study treatment of psychiatric disorders.

Similar proportions of patients were employed (56 % vs 39 %) but the patients in the cognitive behaviour group worked more hours per week (36 vs 24).26 In another study no treatment effect of cognitive behaviour therapy as compared with natural course was found on work rehabilitation although self - rated improvement was associated with cognitive behaviour treatment.27

Not exact matches

An important trigger this year will be the outcome of a study where Darzalex is being tested as first - line treatment in combination with Celgene Corp's Revlimid.

It studies DNA in the blood, detecting biological signs of cancer and then making predictions about where the cancer is and what kind of treatments would work best.

As a result, «we are building on these findings to refine existing treatments to boost feelings of being safe and supported in order to improve coping with traumatic memories,» said Dr. Anke Karl, one of the authors, wrote of the study.

At Battelle, Koper is studying the use of nanomaterials in membranes for water desalination and treatment; supercapacitors (energy - storage devices that provide higher power densities than batteries); and bio-based (rather than petroleum - based) additives used for hydraulic fracturing, or fracking, to retrieve natural gas.

A new study using lab - engineered microtumors allowed doctors to better predict if a cancer drug treatment will work in a patient.

Speaking of checkpoint inhibitor drugs... Merck's star cancer immunotherapy treatment Keytruda is facing some troubling clinical trial incidents which have now compelled the Food and Drug Administration (FDA) to halt three studies of the drug in multiple myeloma, a rare blood cancer, after a number of patient deaths.

Private hospitals are typically the best equipped, with state - of - the art technology and doctors that have studied in the world's best medical universities — many of them speak English and are well acquainted with the newest diagnostic and treatment procedures... some of which may not yet be available in the U.S., for example.

That's striking because the treatment is part of a class called CETP medicines which haven't proven particularly successful in previous studies.

The growing number of people who have the disease is troubling, because there are only four approved drugs that treat symptoms of the disease, and several hopeful treatments have failed key studies in 2017.

Besides randomized controlled clinical trials, there are a number of ways researchers can study how a particular cancer treatment is playing out in the real world: there are retrospective studies, observational studies, and even prospective research done using patient registries.

In a late - stage study, Aimmune, a biotech immunotherapy allergy treatment taken via pill, found that of the roughly 500 kids with peanut allergies between the ages of 4 - 17 who were part of the trial, 67 % of those who received the treatment were able to tolerate 600 milligrams of peanut protein (about two to four peanuts) after about a year of treatment, while only 4 % of those who got the placebo could tolerate that dose of peanut protein.

In the early 1990s, study after study confirmed that women business owners did not receive equal treatment at financial institutions.

Pagan said that a larger, more comprehensive study must be done before determining the drug's true impact, but if the drug's effectiveness is confirmed in such tests, nilotinib could become the first treatment to impede the killing of brain cells that's consistent with Parkinson's, according to NPR.

The study is patient - funded; participants, who range in age from late 30s through 80s, must pay $ 8,000 to take part, and live in or travel to Monterey for treatments and follow - up assessments.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

AUSTRALASIAN Gold Mines NL has given the green light to a project to commission a pilot mining and treatment operation at its Dalgaranga tantalum project in WA by October.The Perth - based company has completed a study to establish a pilot operation,...

«Based on the results from these Phase 3 studies, the combination of bictegravir and FTC / TAF could represent an important advance in triple - therapy treatment for a broad range of HIV patients, and we look forward to submitting regulatory applications in the U.S. and EU this year.»

Although adequate treatment alleviates symptoms and improves productivity, one study found that in the short term, employees may need to take time off to attend clinical appointments or reduce their hours in order to recover.

This test confirmed a significant positive effect of treatment on investment in high variance stocks, both for the cortisol administration study (z = 2.37, P = 0.018) and the testosterone administration study (z = 2.04, P = 0.041, see Fig.

The RadioShack proceedings offer an interesting case study in the treatment of unitranche lenders under two agreements among lenders that existed in that case.

The biotech specialist said that its updated phase 2 data in a study of its poziotinib candidate treatment for non-small cell lung cancer resulted in a preliminary confirmed objective response rate and potential progression - free survival benefit in patients with the EGFR Exon 20 Mutant form of the disease.

The study implies that transportation companies should start implementing in - depth assessment and treatment of sleep apnea among truck drivers.

Patisiran was being evaluated in a late - stage study against a placebo for the treatment of patients with hereditary ATTR (hATTR) amyloidosis with polyneuropathy.

Indeed, in the last six months of the study, «62 per cent of Housing First (HF) participants were housed all of the time... whereas 31 per cent of treatment as usual (TAU) participants were housed all the time...» Further, «Among participants who were housed, housing quality was usually better and more consistent in HF residences than TAU residences.»

Although Lu - PSMA - 617 put up good numbers in its small single - arm study, it still needs to outperform a physician's choice of approved treatments in a much larger global trial.

Investors are therefore going to have to wait for the final ongoing study to wrap up in order to get any real insight into ALKS - 5461's fate as a treatment for MDD.

In contrast, positive expectations of treatment doubled the natural physiological or biochemical effect of the opioid drug among the healthy volunteers in the studIn contrast, positive expectations of treatment doubled the natural physiological or biochemical effect of the opioid drug among the healthy volunteers in the studin the study.

What's missing, in other words, is children with something actually to worry about — worries less amenable to the «low - cost treatment» proposed by NYU's Child Study Center.

Shai, I would encourage you to study the way a virus like Aids changes to survive in spite of all the treatments we throw at it.

Lest common sense fail to convince readers that surgery is not a treatment for a mental disorder, a Swedish study published in 2011 found that over the long term, 324 people who had undergone sex - reassignment surgery demonstrated an alarmingly high suicide rate and experienced considerably higher numbers of severe psychiatric problems than were present in the general population.

At one point Oz mentions his study of Agnon's treatment of God, The Silence of Heaven, whose thesis is that «Agnon believes in God and fears him, but he does not love him.»

It is pathetically significant that over 90 percent of the men in the study had had no systematic treatment.

(And if the organization in question spent time studying the Bible in depth, they'd would both know, and be able to effectively use the treatment plan outlined in the Torah.)

Professor Steve Odin's «A Metaphysics of Cumulative Penetration: Process Theory and Hua - yen Buddhism» (PS 11:65 - 82), is a highly stimulating and challenging essay not only for Whiteheadian and Buddhist studies, but also for its comparative value.1 He has presented a searching analysis of Whiteheadian metaphysics of cumulative penetration, but his treatment of Buddhism in general and Hua - yen in particular in terms of that metaphysics leaves much to be desired, thereby marring the comparative nature of the whole essay.

Although he suggested that it be included within Practical Theology, Schleiermacher made his detailed treatment of mission study in his section on ethics.

On the youth and adult levels, church school curricula ought to include serious study of mental illness, its causes, treatment, and the church's role in prevention.

Professor Steve Odin's «A Metaphysics of Cumulative Penetration: Process Theory and Hua - yen Buddhism» (PS 11:65 - 82), is a highly stimulating and challenging essay not only for Whiteheadian and Buddhist studies, but also for its comparative value.1 He has presented a searching analysis of Whiteheadian metaphysics of cumulative penetration, but his treatment of Buddhism in general and...

Confine burgeoning expenditures to real medical research, early hospitalization costs, and scientific studies; and reduce money's importance as a factor in prevention, treatment, recovery, and the sustenance of government, non-profit, business, and religious agencies.

For detailed instructions for using this exercise in sexual therapy (and enrichment) see William Hartmann and Virginia Fifthian's Treatment of Sexual Dysfunction (Long Beach, Calif.: Center for Marital and Sexual Studies, 1972), pp. 98 - 138.

H. J. Clinebell, Jr «Philosophical - Religious Factors in the Etiology and Treatment of Alcoholism,» Quarterly Journal of Studies on Alcohol, Vol.

Although Whitehead's theory of propositions has received treatment in many general studies of Whitehead's philosophy, it has received little attention as a topic by itself.

Morgan had earlier complained (EEV) about Whitehead's treatment of mind in CN as wholly distinct from nature, and objected to Whitehead's earlier claim that the study of their relations constitutes metaphysics rather than philosophy of science.

What is more, studies have shown that the mates of alcoholics are often almost as disturbed, anxious, and in need of treatment as the alcoholic.

-- «Philosophical - Religious Factors in the Etiology and Treatment of Alcoholism,» in Quarterly Journal of Studies on Alcohol, September, 1963, pp. 473 - 88.

A revealing study of the exploitation of women in counseling and other forms of treatment.

In addition to a helpful glossary and an indispensable index, The Literary Guide features some useful and, in several instances, excellent general essays such as Helen Elsom's superb treatment of the New Testament and Greco - Roman literature, Gerald L. Bruns's brilliant study of midrash and allegory, and an interesting essay by Alter on the characteristics of ancient Hebrew poetrIn addition to a helpful glossary and an indispensable index, The Literary Guide features some useful and, in several instances, excellent general essays such as Helen Elsom's superb treatment of the New Testament and Greco - Roman literature, Gerald L. Bruns's brilliant study of midrash and allegory, and an interesting essay by Alter on the characteristics of ancient Hebrew poetrin several instances, excellent general essays such as Helen Elsom's superb treatment of the New Testament and Greco - Roman literature, Gerald L. Bruns's brilliant study of midrash and allegory, and an interesting essay by Alter on the characteristics of ancient Hebrew poetry.